MEDROGESTONE - PROSPECTIVE STUDY IN PHARMACEUTICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA

被引：10

作者：

PAULSON, DF

KANE, RD

机构：

[1] DUKE UNIV, CTR MED, DIV UROL, DURHAM, NC 27710 USA

[2] VET ADM HOSP, DURHAM, NC 27705 USA

来源：

JOURNAL OF UROLOGY | 1975年 / 113卷 / 06期

关键词：

D O I：

10.1016/S0022-5347(17)59585-3

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：811 / 815

页数：5

共 17 条

[1]

ANTONIPITLAI I, IN PRESS

[2]

CLARKE R, 1937, BRIT J UROL, V9, P254

[3] Male sex hormone therapy [J].

Day, RV .

JOURNAL OF UROLOGY, 1939, 41 (02) :210-219

[4]

GELLER J, 1969, Journal of the American Medical Association, V210, P1421, DOI 10.1001/jama.210.8.1421

[5] TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE - EFFECT ON CLINICAL SYMPTOMS MORPHOLOGY AND ENDOCRINE FUNCTION [J].

GELLER, J ;

BORA, R ;

ROBERTS, T ;

NEWMAN, H ;

LIN, A ;

SILVA, R .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 193 (02) :121-&

[6]

GIVNER ML, 661 AYERST RES LAB D

[7]

GIVNER ML, 1970, CAN FED BIOL SOC, V13, P17

[8]

HORROBIN DF, 1968, LANCET, V1, P170

[9] The effect of castration on benign hypertrophy of the prostate in man [J].

Huggins, C ;

Stevens, RA .

JOURNAL OF UROLOGY, 1940, 43 (05) :705-714

[10] HORMONAL MANAGEMENT OF THE BENIGN OBSTRUCTING PROSTATE - USE OF COMBINED ANDROGEN-ESTROGEN THERAPY [J].

KAUFMAN, JJ ;

GOODWIN, WE .

JOURNAL OF UROLOGY, 1959, 81 (01) :165-171

← 1 2 →